Immunomedics, Inc. (IMMU) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 129.19K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Immunomedics, Inc. (NASDAQ: IMMU) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.18 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
